Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-08-12 Purchase | 2024-08-13 10:55 am | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,600 | $3.13 | $5,008 | 65,000 (Direct) | View |
2024-07-31 Sale | 2024-08-01 12:25 pm | Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary | 2,567 | $4 | $10,268 | 210,536 (Direct) | View |
2023-02-09 Purchase | 2023-02-27 10:52 am | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,500 | $2.8446 | $4,267 | 9,900 (Direct) | View |
2022-10-14 Purchase(A) | 2022-10-18 6:31 pm | Lexaria Bioscience Corp. | LEXX | Downey Gregory Chief Financial Officer | 121 | $2.09 | $253 | 150,787 (Direct) | View |
2022-10-12 Purchase(A) | 2022-10-18 6:20 pm | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 38,500 | $2.0363 | $78,397 | 743,867 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-02 3:45 pm | 2025-02-28 2029-10-01 | Lexaria Bioscience Corp. | LEXX | Shankman Michael Elliot Chief Financial Officer | 0 | $0 | 50,000 (Direct) | View |
Ownership | 2024-09-05 1:09 pm | 2025-02-28 2029-08-31 | Lexaria Bioscience Corp. | LEXX | CHRISTOPHER RICHARD Chief Executive Officer | 0 | $0 | 200,000 (Direct) | View |
2024-07-26 Option Award | 2024-07-30 11:39 am | 2024-07-26 2029-07-26 | Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director | 12,000 | $0 | 98,117 (Direct) | View |
2024-07-26 Option Award | 2024-07-30 11:32 am | 2024-07-26 2029-07-26 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 12,000 | $0 | 61,900 (Direct) | View |
2024-07-26 Option Award | 2024-07-30 11:25 am | 2024-07-26 2029-07-26 | Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director | 12,000 | $0 | 196,200 (Direct) | View |
2024-07-26 Option Award | 2024-07-30 11:12 am | 2024-07-26 2029-07-26 | Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director | 12,000 | $0 | 198,391 (Direct) | View |
2024-05-14 Exercise | 2024-05-15 5:37 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary | 2,500 | $1.15 | 275,670 (Direct) | View |
2024-05-14 Exercise | 2024-05-15 5:37 pm | 2023-10-26 2028-10-26 | Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary | 2,500 | $0 | 275,670 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 5:24 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary | 10,000 | $0 | 213,036 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 5:16 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 5,000 | $0 | 34,900 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 5:11 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director | 5,000 | $0 | 144,200 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 5:03 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director | 5,000 | $0 | 146,391 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 4:52 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director | 5,000 | $0 | 66,117 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 4:44 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 49,500 | $0 | 1,106,794 (Direct) | View |
2024-04-26 Option Award | 2024-05-10 4:34 pm | 2024-04-26 2029-04-26 | Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President | 49,500 | $0 | 606,583 (Direct) | View |
Ownership | 2024-03-15 4:22 pm | 2024-03-15 2029-03-15 | Lexaria Bioscience Corp. | LEXX | Cabatuan Nelson Chief Financial Officer | 0 | $0 | 200,000 (Direct) | View |
2023-10-26 Option Award | 2023-11-01 1:45 pm | 2023-10-26 2028-10-26 | Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary | 12,500 | $0 | 150,469 (Direct) | View |
2023-10-26 Option Award | 2023-10-30 12:47 pm | 2023-10-26 2028-10-26 | Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President | 30,000 | $0 | 432,415 (Direct) | View |
2023-10-26 Option Award | 2023-10-30 12:30 pm | 2023-10-26 2028-10-26 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 30,000 | $0 | 926,293 (Direct) | View |
2023-07-25 Option Award | 2023-07-25 2:35 pm | 2023-07-25 2028-07-25 | Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director | 5,000 | $0 | 104,200 (Direct) | View |
2023-07-25 Option Award | 2023-07-25 2:09 pm | 2023-07-25 2028-07-25 | Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director | 5,000 | $0 | 106,391 (Direct) | View |
2023-07-25 Option Award | 2023-07-25 1:56 pm | 2023-07-25 2028-07-25 | Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director | 5,000 | $0 | 46,117 (Direct) | View |
2023-07-25 Option Award | 2023-07-25 1:44 pm | 2023-07-25 2028-07-25 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 5,000 | $0 | 19,900 (Direct) | View |
2022-10-14 Option Award | 2022-10-18 2:34 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | Downey Gregory Chief Financial Officer | 121 | $2.09 | 150,787 (Direct) | View |
2022-10-12 Option Award | 2022-10-13 5:31 pm | 2022-10-12 2027-10-12 | Lexaria Bioscience Corp. | LEXX | McKechnie William Edward Director | 18,200 | $0 | 71,391 (Direct) | View |
2022-10-12 Option Award | 2022-10-13 5:25 pm | 2022-10-12 2027-10-12 | Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director | 3,200 | $0 | 31,117 (Direct) | View |
2022-10-12 Option Award | 2022-10-13 5:16 pm | 2022-10-12 2027-10-12 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 1,600 | $0 | 8,400 (Direct) | View |
2022-10-12 Option Award | 2022-10-13 5:00 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 21,900 | $1.988 | 1,011,204 (Indirect) | View |
2022-10-13 Option Award | 2022-10-13 5:00 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER CEO | 16,600 | $2.1 | 1,011,204 (Indirect) | View |
2022-10-12 Option Award | 2022-10-13 12:49 pm | 2022-10-12 2027-10-12 | Lexaria Bioscience Corp. | LEXX | Baxter Nicholas W Director | 18,200 | $0 | 69,200 (Direct) | View |
2022-09-02 Option Award | 2022-09-06 12:53 pm | 2022-09-02 2027-09-02 | Lexaria Bioscience Corp. | LEXX | TURKEL CATHERINE C. Director | 3,400 | $0 | 3,400 (Direct) | View |
2022-08-29 Option Award | 2022-08-29 5:32 pm | 2022-08-29 2027-08-29 | Lexaria Bioscience Corp. | LEXX | Carle Vanessa Secretary | 12,500 | $0 | 97,902 (Direct) | View |
2022-08-29 Option Award | 2022-08-29 5:26 pm | 2022-08-29 2027-08-29 | Lexaria Bioscience Corp. | LEXX | DOCHERTY JOHN MARTIN President | 30,000 | $0 | 307,747 (Direct) | View |
2022-08-29 Option Award | 2022-08-29 5:18 pm | 2022-08-29 2027-08-29 | Lexaria Bioscience Corp. | LEXX | BUNKA CHRISTOPHER Chief Executive Officer | 30,000 | $0 | 756,792 (Direct) | View |
2022-08-29 Option Award | 2022-08-29 5:08 pm | 2022-08-29 2027-08-29 | Lexaria Bioscience Corp. | LEXX | Downey Gregory Chief Financial Officer | 11,000 | $0 | 148,833 (Direct) | View |
2022-05-24 Option Award | 2022-05-25 1:48 pm | N/A N/A | Lexaria Bioscience Corp. | LEXX | REESE ALBERT L JR Director | 5,000 | $1.958 | 27,034 (Direct) | View |